Page last updated: 2024-11-10

petroselinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

petroselinic acid: isomer of oleic acid in parsley seeds; RN given refers to cpd without isomeric designation; NM refers to (Z)-isomer; structure in Merck Index, 9th ed, #6974 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

petroselinic acid : The cis-isomer of octadec-6-enoic acid, a long-chain fatty acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5281125
CHEMBL ID3139878
CHEBI ID28194
SCHEMBL ID93332
MeSH IDM0053001

Synonyms (53)

Synonym
ai3-36446
einecs 209-789-8
3a10doc461 ,
unii-3a10doc461
cis-petroselinic acid
(z)-6-octadecenoic acid
cis-octadec-6-enoic acid
cis-omega-12-octadecenoic acid
petroseleninsaeure
cis-delta(6)-octadecenoic acid
petroselinsaeure
CHEBI:28194 ,
octadec-6c-ensaere
(6z)-petroselinic acid
(6z)-octadec-6-enoic acid
6-octadecenoic acid, (z)-
(6z)-6-octadecenoic acid
petroselinic acid
cis-6-octadecenoic acid
(6z)-octadecenoic acid
593-39-5
C08363
petroselinic acid, >=99%, powder
6z-octadecenoic acid
5-heptadecylene-1-carboxylic acid
c18:1n-12
petroselic acid
6-octadecylenic acid
delta-5-octadecylenic acid
LMFA01030066
0DA8F903-431D-46A3-A3AC-0E0BE12DC1EE
octadecenoic acid, 6-(z)-
O0009
(z)-octadec-6-enoic acid
petroselinic acid; petroselic acid; 5-heptadecylene-1-carboxylic acid; delta-5-octadecylenic acid; cis-6-octadecenoic acid; c18:1n-12
BMSE000852
petroselinic acid [mi]
cis-.delta.6-octadecenoic acid
18:1(n-12)
cis-5-heptadecylene-1-carboxylic acid
SCHEMBL93332
AKOS024257458
(6z)-6-octadecenoic acid #
cis- -6-octadecenoic acid
CHEMBL3139878
mfcd00046561
petroselinic acid, analytical standard
Q2080732
HY-113362
CS-0062298
4I1 ,
A935033
DTXSID301026575

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
octadec-6-enoic acidAn octadecenoic acid having a cis- or trans- double bond at position 6.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.03)18.7374
1990's11 (33.33)18.2507
2000's7 (21.21)29.6817
2010's10 (30.30)24.3611
2020's4 (12.12)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.07 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index5.52 (4.65)
Search Engine Demand Index42.91 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.06%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (93.94%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]